Publications

• Transport of xanthurenic acid by rat/human organic anion transporters OAT1 and OAT3.

  Uwai Y., Honjo E.

  Kynurenic acid, a tryptophan metabolite, is involved in psychiatric disease. Our laboratory previously described its transport by rat/human organic anion transporters rOAT1, hOAT1, rOAT3 and hOAT3, which are involved in drug disposition. In this study, we performed an uptake experiment using Xenop ... >> More

  Kynurenic acid, a tryptophan metabolite, is involved in psychiatric disease. Our laboratory previously described its transport by rat/human organic anion transporters rOAT1, hOAT1, rOAT3 and hOAT3, which are involved in drug disposition. In this study, we performed an uptake experiment using Xenopus laevis oocytes to examine the transport of xanthurenic acid, a tryptophan catabolite and kynurenic acid analog, by various transporters. All the transporters tested stimulated the uptake of xanthurenic acid into oocytes. The transport activity of xanthurenic acid by hOAT1 was greater than that by rOAT1. In OAT3, the rat homolog showed efficient transport, compared with hOAT3. The apparent values of Km and Vmax for the transport by hOAT1 were 4.83 µM and 26.0 pmol/oocyte/h respectively. In rOAT3, the respective values were 6.87 µM and 21.7 pmol/oocyte/h. This is the first report on xanthurenic acid transport by OAT1 and OAT3. << Less

  Biosci. Biotechnol. Biochem. 77:1517-1521(2013) [PubMed] [EuropePMC]

  This publication is cited by 1 other entry.

• Interaction and transport of kynurenic acid via human organic anion transporters hOAT1 and hOAT3.

  Uwai Y., Honjo H., Iwamoto K.

  Kynurenic acid, a catabolite of tryptophan, is suggested to be involved in schizophrenia, and is known to be a uremic toxin, although there is little information about the mechanism of its disposition. In this study, we performed uptake experiment using Xenopus laevis oocyte expression system to e ... >> More

  Kynurenic acid, a catabolite of tryptophan, is suggested to be involved in schizophrenia, and is known to be a uremic toxin, although there is little information about the mechanism of its disposition. In this study, we performed uptake experiment using Xenopus laevis oocyte expression system to examine the transport of kynurenic acid by human organic anion transporters hOAT1 (SLC22A6) and hOAT3 (SLC22A8), which mediate the transport of organic anions in the brain and kidney. The uptake of p-aminohippurate in hOAT1-expressing oocytes and of estrone sulfate in hOAT3-expressing oocytes was strongly inhibited by kynurenic acid, and other tryptophan catabolites, kynurenine and quinolinic acid, showed moderate and no inhibition, respectively. The apparent 50% inhibitory concentrations of kynurenic acid were estimated to be 12.9 μM for hOAT1, and 7.76 μM for hOAT3. Both hOAT1 and hOAT3 markedly stimulated the uptake of kynurenic acid into oocytes, and the K(m) values of the transport were calculated to be 5.06 μM and 4.86 μM, respectively. The transport efficiencies of kynurenic acid by hOAT1 and hOAT3 were comparable to those of p-aminohippurate and estrone sulfate, respectively. Probenecid inhibited kynurenic acid transport by hOAT1 and hOAT3. These findings show the interaction of kynurenic acid with hOAT1 and hOAT3, and that kynurenic acid is their substrate. It is suggested that these transporters are involved in the disposition of kynurenic acid. << Less

  Pharmacol. Res. 65:254-260(2012) [PubMed] [EuropePMC]

  This publication is cited by 1 other entry.